Product
IAH0968 + Gemcitabine + Cisplatin
1 clinical trial
1 indication
Indication
HER2 gene mutationClinical trial
Phase Ib/II Clinical Study of IAH0968 in Combination With Gemcitabine and Cisplatin for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors and CholangiocarcinomaStatus: Recruiting, Estimated PCD: 2024-12-01